No abstract available
Keywords:
elderly; malignant lymphomas; morphology; non-hodgkin lymphoma; prognostic factors.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived / immunology
-
Antibodies, Monoclonal, Murine-Derived / pharmacology
-
Antigens, CD20 / analysis
-
Antigens, CD20 / immunology
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers
-
Cyclophosphamide / administration & dosage
-
Disease-Free Survival
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
Immunoglobulin Light Chains / blood*
-
Immunophenotyping
-
Lymphoma, Large B-Cell, Diffuse / blood*
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Male
-
Middle Aged
-
Multicenter Studies as Topic / statistics & numerical data
-
Neoplasm Proteins / blood*
-
Prednisone / administration & dosage
-
Prognosis
-
Randomized Controlled Trials as Topic / statistics & numerical data
-
Rituximab
-
Survival Rate
-
Vincristine / administration & dosage
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20
-
Biomarkers
-
Immunoglobulin Light Chains
-
Neoplasm Proteins
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone